NCT06282809View on ClinicalTrials.gov

The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

July 31, 2026

Conditions
Pancreas CancerAdenocarcinoma of the PancreasPancreatic CancerTumor of Pancreas
Interventions
DEVICE

HistoSonics Edison™ System for the treatment of pancreatic adenocarcinoma using histotripsy

Histotripsy is a non-thermal, mechanical process of focused ultrasound used to mechanically destroy targeted soft tissue.

Trial Locations (1)

Unknown

RECRUITING

Hospital de la Santa Creu i Sant Pau, Barcelona

Sponsors

Lead Sponsor

HistoSonics, Inc.
All Listed Sponsors
lead

HistoSonics, Inc.

INDUSTRY

NCT06282809 - The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy | Biotech Hunter | Biotech Hunter